Skip to main content
    P

    Precipio Inc (PRPO)

    Official site

    HEALTHCARE • DIAGNOSTICS & RESEARCH • NASDAQ

    $19.96
    -2.17 (-9.81%)

    Market Cap: $39.68M

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Precipio Inc (PRPO) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to Precipio are Insight Molecular Diagnostics (IMDX), MDxHealth SA (MDXH) and Exagen (XGN). By market cap, Precipio ranks 8th of the 13 companies on this page; Revvity (RVTY) is the largest at $17.24B.

    Peer Comparison

    PRPO's ROIC of -5.7% is above the peer median of -29.5%, and its revenue growth of 8.3% is above the median of 0.0%. Like the median peer, it pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    Precipio (PRPO)$39.68MN/A1.3x-4.1%-5.7%8.3%0.00%
    Insight Molecular Diagnostics Inc. (IMDX)$70.03MN/A40.9x0.0%197.8%-53.9%0.00%
    MDxHealth SA (MDXH)$13.75MN/AN/A-38.3%-40.5%-17.2%0.00%
    Exagen Inc (XGN)$105.37MN/A1.3x-25.1%-40.4%6.8%0.00%
    Personalis Inc (PSNL)$1.70BN/A20.9x-147.7%N/A76.6%0.00%
    Quince Therapeutics, Inc. (QNCX)$32.27MN/AN/A0.0%N/A0.0%0.00%
    Myriad Genetics Inc (MYGN)$542.92MN/A0.7x-16.1%-29.5%-1.5%0.00%
    Revvity Inc. (RVTY)$17.24B26.8x5.6x8.6%3.4%4.3%0.19%
    NextCure Inc (NXTC)$29.31MN/AN/A0.0%N/A-100.0%0.00%
    Plus Therapeutics Inc (PSTV)$26.64MN/A2.0x-230.2%-827.8%-2.9%0.00%
    Instil Bio Inc. (TIL)$41.23MN/AN/A0.0%-11.9%0.0%0.00%
    Veru Inc (VERU)$35.64MN/AN/A0.0%N/A18.3%0.00%
    CareDx Inc (CDNA)$4.09B48.2x6.4x25.9%N/A39.3%0.00%
    Peer median$55.63M37.5x5.6x0.0%-29.5%0.0%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to Precipio, ranked by how closely their business, size, sector and industry match. The largest group, 7 of the 12, is in Diagnostics & Research; the other 5 are in Biotechnology.

    CompanyAboutPeers
    Insight Molecular Diagnostics Inc. (IMDX)Diagnostics & Research
    OncoCyte Corporation is a precision diagnostics company in the United States and internationally. The company is headquartered in Irvine, California.
    IMDX competitors
    MDxHealth SA (MDXH)Diagnostics & Research
    MDxHealth SA is a prominent biotechnology company focused on precision diagnostics that enhance cancer management, particularly in prostate and bladder cancers.
    MDXH competitors
    Exagen Inc (XGN)Diagnostics & Research
    Exagen Inc. develops and markets various test products based on its Cell-Bound Complement Activation Products technology under the AVISE brand name...
    XGN competitors
    Personalis Inc (PSNL)Diagnostics & Research
    Personalis, Inc. is a global cancer genomics company. The company is headquartered in Menlo Park, California.
    PSNL competitors
    Quince Therapeutics, Inc. (QNCX)Biotechnology
    Quince Therapeutics, Inc., a biopharmaceutical company, is focused on advancing precision therapies for rare and debilitating diseases.
    Myriad Genetics Inc (MYGN)Diagnostics & Research
    Myriad Genetics, Inc., a molecular diagnostics company, develops and markets predictive, personalized...
    MYGN competitors
    Revvity Inc. (RVTY)Diagnostics & Research
    Revvity, Inc. provides products, services, and solutions to the diagnostics, life sciences, and applied services markets globally.
    RVTY competitors
    NextCure Inc (NXTC)Biotechnology
    NextCure, Inc., a clinical-stage biopharmaceutical company, is dedicated to the discovery and development of novel immunomedicines to treat cancer and other...
    NXTC competitors
    Plus Therapeutics Inc (PSTV)Biotechnology
    Plus Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the development, manufacturing...
    PSTV competitors
    Instil Bio Inc. (TIL)Biotechnology
    Instil Bio, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer patients.
    TIL competitors
    Veru Inc (VERU)Biotechnology
    Veru Inc., an oncology biopharmaceutical company, focuses on the development of drugs for the treatment of cancers.
    VERU competitors
    CareDx Inc (CDNA)Diagnostics & Research
    CareDx, Inc. discovers, develops and markets diagnostic solutions for transplant patients and caregivers globally.
    CDNA competitors

    Frequently Asked Questions About PRPO

    Who are Precipio's main competitors?

    The companies most similar to Precipio include Insight Molecular Diagnostics (IMDX), MDxHealth SA (MDXH), Exagen (XGN), Personalis (PSNL) and Quince Therapeutics (QNCX), listed from the closest match.

    Who is Precipio's biggest competitor?

    Revvity (RVTY) is the largest of the similar companies at $17.24B; Insight Molecular Diagnostics (IMDX) is the closest match by business profile, size, sector and industry.

    How does PRPO stock compare with its competitors?

    PRPO's P/S is 1.3x against a peer median of 5.6x; its net margin is -4.1% against a peer median of 0.0%.

    Which of Precipio's competitors pays a higher dividend?

    Precipio pays no dividend. Revvity (RVTY) has a higher forward dividend yield; Revvity (RVTY) has the highest at 0.19%.

    Is Precipio bigger than its competitors?

    No. Precipio is 8th by market cap among the 13 companies on this page; the largest is Revvity (RVTY) at $17.24B.